Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Brain acid soluble protein 1 (BASP1) is a highly conserved, membrane-associated signal processing protein that is particularly abundant in the brain, where it is involved in the regulation of synaptic plasticity, neurite outgrowth, and neural development[1][3][8][9]. BASP1 belongs to a family of growth-associated proteins (including CAP23 and GAP43), is myristoylated at its N-terminus, and contains phosphorylation sites and PEST motifs which indicate rapid protein turnover[2][3][6][8]. It has multifunctional roles, acting as a transcriptional corepressor in complex with Wilms’ tumor protein (WT1), and as a tumor suppressor interfering with oncogenic pathways (e.g., MYC)[3][7]. During neural development, BASP1 is expressed in neural stem cells and is required for survival—gene knockout is lethal in mice[1]. BASP1 is also present in some non-neural tissues and its altered expression has been associated with cancer, making it a possible biomarker for both neural progenitor identification and oncological prognosis[3][7][1]. No direct pharmacological interventions currently target BASP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain acid soluble protein 1 (BASP1).